Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Penile Neoplasms × cemiplimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 5 Skin Neoplasms 5 Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Merkel Cell 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Mycosis Fungoides 3 Melanoma 3 Carcinoma, Squamous Cell 3 Breast Neoplasms 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Oropharyngeal Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Vulvar Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1

Interventions

pembrolizumab 4 Paclitaxel 4 Ifosfamide 4 Cisplatin 4 Nivolumab 3 avelumab 2 Magnetic Resonance Spectroscopy 2 vinflunine 1 toripalimab 1 niraparib 1 nimotuzumab 1 enfortumab vedotin 1 dostarlimab 1 dacomitinib 1 cemiplimab 1 cabazitaxel 1 aldesleukin 1 Vorinostat 1 Ultrasonography 1 Surveys and Questionnaires 1 Sildenafil Citrate 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Psychiatric Nursing 1 Physical Therapy Modalities 1 Palliative Care 1 Magnetic Resonance Imaging 1 Isotretinoin 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07101822 2025-08-03

BRAVA PENILE

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡